Forsta Ap-fonden adds Thermo Fisher Scientific (TMO) to its portfolio

Thermo Fisher Scientific (TMO) : Forsta Ap-fonden added new position in Thermo Fisher Scientific during the most recent quarter end. The investment management firm now holds 201,970 shares of Thermo Fisher Scientific which is valued at $31,802,196 , the company said in a statement filed on Aug 8, 2016 with the SEC.Thermo Fisher Scientific makes up approximately 0.90% of Forsta Ap-fonden’s portfolio.

Other Hedge Funds, Including , Bnp Paribas Investment Partners S.a. reduced its stake in TMO by selling 38,351 shares or 9.19% in the most recent quarter. The Hedge Fund company now holds 378,841 shares of TMO which is valued at $59,652,304. Thermo Fisher Scientific makes up approx 0.51% of Bnp Paribas Investment Partners S.a.’s portfolio.Commonwealth Equity Services Inc boosted its stake in TMO in the latest quarter, The investment management firm added 1,132 additional shares and now holds a total of 27,621 shares of Thermo Fisher Scientific which is valued at $4,350,584. Thermo Fisher Scientific makes up approx 0.04% of Commonwealth Equity Services Inc’s portfolio.Sumitomo Mitsui Asset Management Company Ltd reduced its stake in TMO by selling 6,882 shares or 11.75% in the most recent quarter. The Hedge Fund company now holds 51,696 shares of TMO which is valued at $8,211,393. Thermo Fisher Scientific makes up approx 0.24% of Sumitomo Mitsui Asset Management Company Ltd’s portfolio.Flossbach Von Storch Ag reduced its stake in TMO by selling 20,960 shares or 36.13% in the most recent quarter. The Hedge Fund company now holds 37,060 shares of TMO which is valued at $5,886,610. Thermo Fisher Scientific makes up approx 0.10% of Flossbach Von Storch Ag’s portfolio.Coastline Trust Co reduced its stake in TMO by selling 360 shares or 0.88% in the most recent quarter. The Hedge Fund company now holds 40,410 shares of TMO which is valued at $6,372,253. Thermo Fisher Scientific makes up approx 1.26% of Coastline Trust Co’s portfolio.

Thermo Fisher Scientific opened for trading at $155.69 and hit $156.46 on the upside on Monday, eventually ending the session at $155.97, with a gain of 0.31% or 0.48 points. The heightened volatility saw the trading volume jump to 9,59,130 shares. Company has a market cap of $61,493 M.

On the company’s financial health, Thermo Fisher Scientific reported $2.03 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $2.01. The company had revenue of $4535.20 million for the quarter, compared to analysts expectations of $4493.28 million. The company’s revenue was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.84 EPS.

Investors should note that on Jul 7, 2016, Thermo Fisher Scientific announced a cash dividend of $0.1500. The company’s management has announced Sep 13, 2016 as the ex-dividend date and fixed the record date on Sep 15, 2016. The payable date has been fixed on Oct 17, 2016.

Many Wall Street Analysts have commented on Thermo Fisher Scientific. Company shares were Reiterated by Mizuho on May 27, 2016 to “Buy”, Firm has raised the Price Target to $ 170 from a previous price target of $166 .Company shares were Reiterated by Mizuho on May 19, 2016 to “Buy”, Firm has raised the Price Target to $ 166 from a previous price target of $163 .

Thermo Fisher Scientific Inc. is a provider of analytical instruments equipment reagents and consumables software and services for research manufacturing analysis discovery and diagnostics. The company operates through four segments: Life Sciences Solutions provides reagents instruments and consumables used in biological and medical research discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments provides instruments consumables software and services that are used in the laboratory; Specialty Diagnostics offers diagnostic test kits reagents culture media instruments and associated products and Laboratory Products and Services offers self-manufactured and sourced products for the laboratory.

Leave a Reply

Thermo Fisher Scientific - Is it time to Sell?

Top Brokerage Firms are advising their investors on Thermo Fisher Scientific. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.